Congress Asset Management CO Relay Therapeutics, Inc. Transaction History
Congress Asset Management CO
- $14.3 Billion
- Q3 2024
A detailed history of Congress Asset Management CO transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Congress Asset Management CO holds 146,424 shares of RLAY stock, worth $899,043. This represents 0.01% of its overall portfolio holdings.
Number of Shares
146,424
Previous 147,610
0.8%
Holding current value
$899,043
Previous $962,000
7.69%
% of portfolio
0.01%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding RLAY
# of Institutions
182Shares Held
128MCall Options Held
16.7KPut Options Held
18K-
Sb Investment Advisers (Uk) LTD London, X027.9MShares$171 Million1.68% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$71.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.5MShares$64.7 Million0.0% of portfolio
-
Casdin Capital, LLC New York, NY8.45MShares$51.9 Million4.75% of portfolio
-
Bellevue Group Ag Kuesnacht, V86.38MShares$39.2 Million0.7% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $738M
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...